Egide (ALGID) H2 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 TU earnings summary
26 Jan, 2026Executive summary
Consolidated revenue reached €31.34m for 2025, up 4% year-over-year, driven by strategic repositioning and growth in high-tech segments.
Strong recovery in Europe (+30%) and robust growth in the thermal imaging segment (+56%), now the largest revenue contributor.
Governance changes included a new CEO and Board, focusing on industrial synergies and critical applications in defense, optronics, and aerospace.
Financial highlights
Egide SA revenue grew 12% to €16.50m, led by thermal imaging and optronics.
Egide USA revenue increased 29% to €10.75m, driven by technical applications in defense and aerospace.
Santier revenue declined 41% to €4.09m due to discontinued high-value programs.
Thermal imaging segment revenue rose 56% to €14.19m, now 45% of total revenue.
Revenue by region: Europe +30%, North America -5%, Asia & ROW -5%.
Outlook and guidance
2026 priorities include further diversification of the customer base, improved operating performance, and increased industrial synergies.
Focus remains on key technologies and reducing dependence on a few major accounts.
Latest events from Egide
- EBITDA turned positive as revenue rose 1%, but net loss widened due to Santier’s downturn.ALGID
H1 202522 Oct 2025 - 2024 revenue dropped 15.5%, but single-digit growth is forecast for 2025.ALGID
H2 202410 Sep 2025 - Thermal imaging and European growth drove a return to revenue expansion in H1 2025.ALGID
H1 2025 TU30 Jul 2025 - H1 2024 sales dropped 19%, but a €1.8M capital increase aims to support future growth.ALGID
H1 202413 Jun 2025 - 2024 revenue fell 15.5%, but single-digit growth is forecast for 2025.ALGID
H2 2024 TU6 Jun 2025